DK0572549T3 - Behandling af ikke-småcellet lungecarcinom - Google Patents

Behandling af ikke-småcellet lungecarcinom

Info

Publication number
DK0572549T3
DK0572549T3 DK92907467T DK92907467T DK0572549T3 DK 0572549 T3 DK0572549 T3 DK 0572549T3 DK 92907467 T DK92907467 T DK 92907467T DK 92907467 T DK92907467 T DK 92907467T DK 0572549 T3 DK0572549 T3 DK 0572549T3
Authority
DK
Denmark
Prior art keywords
small cell
cell lung
lung carcinoma
treatment
human
Prior art date
Application number
DK92907467T
Other languages
Danish (da)
English (en)
Inventor
Randall Keith Johnson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DK0572549T3 publication Critical patent/DK0572549T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK92907467T 1991-02-21 1992-02-07 Behandling af ikke-småcellet lungecarcinom DK0572549T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65893791A 1991-02-21 1991-02-21
PCT/US1992/001034 WO1992014471A1 (en) 1991-02-21 1992-02-07 Treatment of non-small cell lung carcinoma

Publications (1)

Publication Number Publication Date
DK0572549T3 true DK0572549T3 (da) 2003-01-06

Family

ID=24643331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92907467T DK0572549T3 (da) 1991-02-21 1992-02-07 Behandling af ikke-småcellet lungecarcinom

Country Status (14)

Country Link
US (1) US5756512A (de)
EP (1) EP0572549B1 (de)
JP (1) JP2738979B2 (de)
KR (1) KR930702984A (de)
AT (1) ATE227991T1 (de)
AU (2) AU1531992A (de)
CA (1) CA2103707C (de)
DE (1) DE69232852T2 (de)
DK (1) DK0572549T3 (de)
ES (1) ES2187500T3 (de)
HK (1) HK1012267A1 (de)
MX (1) MX9200755A (de)
PT (1) PT100155B (de)
WO (1) WO1992014471A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7732996A (en) * 1995-11-22 1997-06-11 Research Triangle Institute Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties
US6096336A (en) * 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
US6352996B1 (en) 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
KR102456088B1 (ko) 2014-04-04 2022-10-19 델 마 파마슈티컬스 폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells

Also Published As

Publication number Publication date
CA2103707C (en) 2003-12-09
PT100155A (pt) 1993-05-31
WO1992014471A1 (en) 1992-09-03
PT100155B (pt) 1999-09-30
US5756512A (en) 1998-05-26
DE69232852D1 (de) 2003-01-02
KR930702984A (ko) 1993-11-29
ES2187500T3 (es) 2003-06-16
JPH06505741A (ja) 1994-06-30
DE69232852T2 (de) 2003-09-04
CA2103707A1 (en) 1992-08-22
AU4042795A (en) 1996-02-22
EP0572549A4 (de) 1994-01-12
EP0572549B1 (de) 2002-11-20
JP2738979B2 (ja) 1998-04-08
HK1012267A1 (en) 1999-07-30
ATE227991T1 (de) 2002-12-15
AU699436B2 (en) 1998-12-03
EP0572549A1 (de) 1993-12-08
AU1531992A (en) 1992-09-15
MX9200755A (es) 1992-08-01

Similar Documents

Publication Publication Date Title
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
FI946173A (fi) Menetelmä lääkeaineiden antotehon parantamiseksi muunnettujen saponiinien avulla
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
KR950700749A (ko) 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
DK0572549T3 (da) Behandling af ikke-småcellet lungecarcinom
DK67683D0 (da) Fremgangsmade til fremstilling af 2,3-diaryl-5-halogen-thio-phener
DK0588873T3 (da) Behandling af levercancer
IS4847A (is) Aðferð til meðferðar gegn hjartabilun þar sem notuð eru mótlyf gegn endóþelíni
DK1076561T3 (da) Kombinationsterapi til behandlingen af tumorer
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
AU562828B2 (en) Morphine-vitamin b12 analgesic treatment
CA2103708A1 (en) Treatment of ovarian cancer
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
NO984196L (no) FremgangsmÕte for behandling av stoffmisbruk
NO984198D0 (no) Fremgangsmåte for behandling av aggresjon
JPS51148963A (en) Sludge and pollut ed earth treatment
DK0671918T3 (da) Præparater indeholdende acyclovir-lignende forbindelser og 2-vinylsubstituerede nucleosidanaloge til behandling af virusinfektioner
RO86650B1 (ro) Preparat farmaceutic pentru tratarea dermatozelor
ZA775145B (en) Improvements in the treatment of effluents
GB2188312B (en) Improvements in or relating to the treatment of waters
GR900100664A (en) Method of sewage treatment in the soil
BG34201A1 (en) Method for potentiating the effect of cytostatic agents in chemical treatment of cancer
UA30787A (uk) Спосіб лікування хронічного персистуючого гепатиту